SLN
Silence Therapeutics
$12.07
+$1.05 (+9.53%)Jul 27, 2026
Key metrics
The numbers that frame SLN today
- Market cap
- $569.55M
- P/E (TTM)
- -7.6
- EV / FCF
- -8.6
- Gross margin
- 79.5%
- EV / Sales
- 672.3
- ROIC
- -94.1%
- Div yield
- 0%
- 52wk Low
- $4.19
- 52wk High
- $12.19
Growth
Revenue and earnings trend for SLN
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about SLN
Is Silence Therapeutics a good buy?
Hold. Silence Therapeutics has excellent momentum, but poor quality makes the setup mixed. Growth looks excellent, which supports the long-term business case. We think Silence Therapeutics is selling at a very high price.
What is the market capitalization of SLN?
Silence Therapeutics's market capitalization is $569.55M.
What is the P/E ratio for SLN stock?
Silence Therapeutics's current P/E ratio is -7.6.
What is the 52-week high for SLN stock?
The 52-week high for Silence Therapeutics is $12.19. The current close of $12.07 is 1% below that high.
What is the 52-week low for SLN stock?
The 52-week low for Silence Therapeutics is $4.19. The current close of $12.07 is 188.1% above that low.
Does SLN stock pay dividends?
Silence Therapeutics does not currently show a dividend per share in the company data.